Cargando…

Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients

Transarterial chemoembolization (TACE) is usually followed by hepatic dysfunction. We evaluated the effects of L-carnitine on post-TACE impaired liver functions. Methods. 53 cirrhotic hepatocellular carcinoma patients at Osaka Medical College were enrolled in this study and assigned into either L-ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Abeer, Tsuda, Yasuhiro, Asai, Akira, Yokohama, Keisuke, Nakamura, Ken, Sujishi, Tetsuya, Ohama, Hideko, Tsuchimoto, Yusuke, Fukunishi, Shinya, Abdelaal, Usama M., Arafa, Usama A., Hassan, Ali T., Kassem, Ali M., Higuchi, Kazuhide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668308/ https://www.ncbi.nlm.nih.gov/pubmed/26664151 http://dx.doi.org/10.1155/2015/608216

Ejemplares similares

Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice
por: Sujishi, Tetsuya, et al.
Publicado: (2015)

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)

Association between Administration of Antithrombotics and Intraperitoneal Hemorrhage in Patients Undergoing Percutaneous Interventions for Liver Diseases
por: Asai, Akira, et al.
Publicado: (2021)

Is administrating branched-chain amino acid-enriched nutrition achieved symptom-free in malnourished cirrhotic patients?
por: Tsuda, Yasuhiro, et al.
Publicado: (2014)

Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
por: Yasuoka, Hidetaka, et al.
Publicado: (2020)

The preventive effect of the impaired liver function for antiemetic therapy against chemotherapy-induced nausea and vomiting in hepatocellular carcinoma patients
por: Nishikawa, Tomohiro, et al.
Publicado: (2017)

Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
por: Inoue, Yoshihiro, et al.
Publicado: (2020)

Hepatectomy and liver regeneration in the results of treatment of colorectal liver metastasis
por: Inoue, Yoshihiro, et al.
Publicado: (2020)

Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study
por: Inoue, Yoshihiro, et al.
Publicado: (2021)

Liver dysfunction is associated with poor prognosis in patients after immune checkpoint inhibitor therapy
por: Yokohama, Keisuke, et al.
Publicado: (2020)

CD34(+)CD10(+)CD19(−) Cells in Patients with Unhealthy Alcohol Use Stimulate the M2b Monocyte Polarization
por: Asai, Akira, et al.
Publicado: (2022)

Evaluation of Portal Hypertensive Enteropathy by Scoring with Capsule Endoscopy: Is Transient Elastography of Clinical Impact?
por: Abdelaal, Usama M., et al.
Publicado: (2010)

Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
por: Chen, Junwei, et al.
Publicado: (2023)

Comparison of SARC-F Score among Gastrointestinal Diseases
por: Ushiro, Kosuke, et al.
Publicado: (2021)

Prognostic Impact of the SARC-F Score in Gastrointestinal Advanced Cancers
por: Matsui, Masahiro, et al.
Publicado: (2021)

Programmed Death 1 Ligand Expression in the Monocytes of Patients with Hepatocellular Carcinoma Depends on Tumor Progression
por: Asai, Akira, et al.
Publicado: (2020)

The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases
por: Ikegami, Takako, et al.
Publicado: (2022)

The Relevance in the Neutrophil to Lymphocyte Ratio and the SARC-F Score in Gastrointestinal Diseases
por: Yamasaki, Eiki, et al.
Publicado: (2022)

Grip Strength in Patients with Gastrointestinal Diseases
por: Asaishi, Ken, et al.
Publicado: (2022)

Accurate SARC-F Score in Patients with Liver Disease
por: Matsui, Masahiro, et al.
Publicado: (2023)

Endoscopic Ultrasound-Guided Pancreatic Transmural Stenting and Transmural Intervention
por: Ogura, Takeshi, et al.
Publicado: (2020)

Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort
por: Young, Shamar, et al.
Publicado: (2021)

Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study
por: Fu, Zhigang, et al.
Publicado: (2021)

Efficacy and Safety of Transarterial Chemoembolization with DC Beads LUMI in the Treatment of HCC: Experience from a Tertiary Centre
por: Biondetti, Pierpaolo, et al.
Publicado: (2023)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016)

Laparoscopic liver resection for patients with cardiac disease
por: Inoue, Yoshihiro, et al.
Publicado: (2019)

Transarterial chemoembolization (TACE) with degradable starch microspheres (DSM) in hepatocellular carcinoma (HCC): multi-center results on safety and efficacy
por: Schicho, Andreas, et al.
Publicado: (2017)

Multi-Task Deep Learning Approach for Simultaneous Objective Response Prediction and Tumor Segmentation in HCC Patients with Transarterial Chemoembolization
por: Li, Yuze, et al.
Publicado: (2022)

Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score
por: Gong, Baocuo, et al.
Publicado: (2023)

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma
por: Fukushima, Taito, et al.
Publicado: (2021)

Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
por: Adel, Hatem, et al.
Publicado: (2023)

Efficacy evaluation of the combination therapy of sorafenib and transarterial chemoembolization for unresectable HCC: a systematic review and meta-analysis of comparative studies
por: Li, Huichen, et al.
Publicado: (2020)

A new prediction model for prognosis of patients with intermediate-stage HCC after conventional transarterial chemoembolization: an internally validated study
por: Chen, Rong-Xin, et al.
Publicado: (2019)

Spontaneous regression of lung metastases after transarterial chemoembolization for hepatocellular carcinoma
por: Kakuta, Naoko, et al.
Publicado: (2021)

Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)
por: Lin, Xiao-jun, et al.
Publicado: (2015)

Rapid aneurysm growth after transarterial chemoembolization
por: Dansey, Kirsten, et al.
Publicado: (2015)

Ultraselective conventional transarterial chemoembolization: When and how?
por: Miyayama, Shiro
Publicado: (2019)

Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Vardar, Baran U, et al.
Publicado: (2022)

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nqt26u08lsh5e9pei2nsi3eu9c